352
Participants
Start Date
February 28, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
December 31, 2015
Mercy Medical Center, Baltimore
Investigative Clinical Research, Annapolis
Digestive and Liver Disease Specialists, Norfolk
Infectious Diseases Associates of Central Virginia, Lynchburg
Duke University Medical Center, Durham
Cumberland Research Associates, LLC, Fayetteville
Asheville Gastroenterology Associates, PA, Asheville
Charleston GI Specialists, Charleston
Gastrointestinal Specialists of Georgia, Marietta
Atlanta Gastroenterology Associates, Atlanta
Schiff Center for Liver Disease, Miami
Nashville Medical Research Institute, Nashville
Quality Medical Research, PLLC, Nashville
Indianapolis Gastroenterology Research Facility, Indianapolis
Kansas City Gastroenterology, Kansas City
Arkansas Gastroenterology, North Little Rock
Options Health Research, LLC, Tulsa
Cure C Consortium, Houston
Liver Associates of Texas, P.A., Houston
Research Specialists of Texas, Houston
The Texas Liver Institute, San Antonio
Central Texas Clinical Research, Austin
Austin Center for Clinical Research, Austin
South Denver Gastroenterology, PC, Englewood
Empire Clinical Research, Upland
Inland Empire Liver Foundation, Rialto
Island View Gastroenterology, Ventura
Franco Felizarta, MD, Bakersfield
Kaiser Permanente, San Francisco
University of Washington, Seattle
Yale School of Medicine, New Haven
Commonwealth Clinical Studies, Brockton
The Research Institute, Springfield
Fundacion de Investigacion de Diego, San Juan
Lead Sponsor
Hologic, Inc.
INDUSTRY